V.Kate Hirst

942 total citations
14 papers, 787 citations indexed

About

V.Kate Hirst is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, V.Kate Hirst has authored 14 papers receiving a total of 787 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cancer Research, 6 papers in Pulmonary and Respiratory Medicine and 4 papers in Molecular Biology. Recurrent topics in V.Kate Hirst's work include Cancer, Hypoxia, and Metabolism (6 papers), Radiation Therapy and Dosimetry (3 papers) and Cancer Research and Treatments (2 papers). V.Kate Hirst is often cited by papers focused on Cancer, Hypoxia, and Metabolism (6 papers), Radiation Therapy and Dosimetry (3 papers) and Cancer Research and Treatments (2 papers). V.Kate Hirst collaborates with scholars based in United States, Canada and United Kingdom. V.Kate Hirst's co-authors include Elaine M. Zeman, Marilyn J. Lemmon, Jeremy Brown, William W. Lee, J. Martin Brown, Joanne Halsey, C. Norman Coleman, Raul C. Urtasun, Todd H. Wasserman and Steven Hancock and has published in prestigious journals such as International Journal of Radiation Oncology*Biology*Physics, Radiotherapy and Oncology and Gynecologic Oncology.

In The Last Decade

V.Kate Hirst

14 papers receiving 772 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
V.Kate Hirst United States	9	409	307	135	133	129	14	787
Elaine M. Zeman United States	16	461 1.1×	364 1.2×	124 0.9×	178 1.3×	130 1.0×	38	978
John Nolan United Kingdom	16	277 0.7×	409 1.3×	148 1.1×	57 0.4×	85 0.7×	28	787
Sara A. Fitzsimmons United Kingdom	7	207 0.5×	281 0.9×	77 0.6×	64 0.5×	55 0.4×	8	555
Yi-Wen Chu Taiwan	8	389 1.0×	806 2.6×	305 2.3×	128 1.0×	104 0.8×	8	1.3k
E. Friedrich Germany	19	97 0.2×	333 1.1×	179 1.3×	166 1.2×	155 1.2×	48	1.0k
Norma J. Nelson United States	16	362 0.9×	243 0.8×	160 1.2×	213 1.6×	115 0.9×	47	1000
A.E.C. Korst Belgium	16	89 0.2×	292 1.0×	264 2.0×	158 1.2×	58 0.4×	20	681
Peter A. Harris United Kingdom	11	123 0.3×	293 1.0×	141 1.0×	51 0.4×	88 0.7×	19	587
Alex J. Eustace Ireland	20	347 0.8×	688 2.2×	429 3.2×	163 1.2×	82 0.6×	52	1.2k
Rodolfo A. Medina United Kingdom	15	385 0.9×	563 1.8×	197 1.5×	122 0.9×	47 0.4×	23	1.1k

Countries citing papers authored by V.Kate Hirst

Since Specialization

Citations

This map shows the geographic impact of V.Kate Hirst's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V.Kate Hirst with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V.Kate Hirst more than expected).

Fields of papers citing papers by V.Kate Hirst

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V.Kate Hirst. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V.Kate Hirst. The network helps show where V.Kate Hirst may publish in the future.

Co-authorship network of co-authors of V.Kate Hirst

This figure shows the co-authorship network connecting the top 25 collaborators of V.Kate Hirst. A scholar is included among the top collaborators of V.Kate Hirst based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V.Kate Hirst. V.Kate Hirst is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Rojas, Anamaria, et al.. (1996). Carbogen and nicotinamide as radiosensitizers in a murine mammary carcinoma using conventional and accelerated radiotherapy. International Journal of Radiation Oncology*Biology*Physics. 34(2). 357–365. 49 indexed citations

Hirst, David G., Barbara Joiner, & V.Kate Hirst. (1994). Is Oxygen the Limiting Substrate for the Expansion of Cords Around Blood Vessels in Tumours?. Advances in experimental medicine and biology. 345. 431–436. 1 indexed citations

Stone, Helen B., et al.. (1991). A comparison of radiosensitization by etanidazole and pimonidazole in mouse tumors. International Journal of Radiation Oncology*Biology*Physics. 20(5). 987–995. 3 indexed citations

Zeman, Elaine M., et al.. (1988). Metabolism of SR 4233 by Chinese hamster ovary cells: basis of selective hypoxic cytotoxicity.. PubMed. 48(21). 5947–52. 105 indexed citations

Zeman, Elaine M., V.Kate Hirst, Marilyn J. Lemmon, & Jeremy Brown. (1988). Enhancement of radiation-induced tumor cell killing by the hypoxic cell toxin SR 4233. Radiotherapy and Oncology. 12(3). 209–218. 75 indexed citations

Horsman, Michael R., J. Martin Brown, D. Phil, et al.. (1988). Mechanism of action of the selective tumor radiosensitizer nicotinamide. International Journal of Radiation Oncology*Biology*Physics. 15(3). 685–690. 65 indexed citations

Horsman, Michael R., J. Martin Brown, V.Kate Hirst, Marilyn J. Lemmon, & Eamonn P. Dunphy. (1987). Mechanism of action and clinical potential of the selective tumor radiosensitizer nicotinamide. International Journal of Radiation Oncology*Biology*Physics. 13. 109–109. 5 indexed citations

Coleman, C. Norman, Todd H. Wasserman, Raul C. Urtasun, et al.. (1986). Phase I trial of the hypoxic cell radiosensitizer SR-2508: The results of the five to six week drug schedule. International Journal of Radiation Oncology*Biology*Physics. 12(7). 1105–1108. 52 indexed citations

Zeman, Elaine M., Jeremy Brown, Marilyn J. Lemmon, V.Kate Hirst, & William W. Lee. (1986). SR-4233: A new bioreductive agent with high selective toxicity for hypoxic mammalian cells. International Journal of Radiation Oncology*Biology*Physics. 12(7). 1239–1242. 327 indexed citations

10.

Coleman, C. Norman, Raul C. Urtasun, Todd H. Wasserman, et al.. (1984). Results of the phase I trial of the hypoxic cell radiosensitizer SR 2508. International Journal of Radiation Oncology*Biology*Physics. 10. 129–129. 8 indexed citations

11.

Coleman, C. Norman, Raul C. Urtasun, Todd H. Wasserman, et al.. (1984). Initial report of the phase I trial of the hypoxic cell radiosensitizer SR-2508. International Journal of Radiation Oncology*Biology*Physics. 10(9). 1749–1753. 73 indexed citations

12.

Coleman, C. Norman, Samuel C. Ballon, Anthony E. Howes, et al.. (1984). The current status of drug development of hypoxic cell radiosensitizers and their potential role in gynecologic oncology. Gynecologic Oncology. 18(1). 18–27. 4 indexed citations

13.

Coleman, C. Norman, V.Kate Hirst, Dennis Brown, & Joanne Halsey. (1984). The effect of vitamin b6 on the neurotoxicity and pharmacology of desmethylmisonidazole and misonidazole: Clinical and laboratory studies. International Journal of Radiation Oncology*Biology*Physics. 10(8). 1381–1386. 6 indexed citations

14.

Coleman, C. Norman, Charlotte Jacobs, Joanne Halsey, et al.. (1983). Phase I trial of intravenous L-phenylalanine mustard plus the sensitizer misonidazole.. PubMed. 43(10). 5022–5. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact